SymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication of late-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.

The driving force behind SymPhysis Medical is an unwavering commitment to provide independence and improved quality of life for patients with chronic conditions and those requiring palliative care.

Through clinical immersion and using a ‘needs-based’ innovation approach, we have identified limitations associated with current treatments for MPE. Through collaborating with clinicians, public health nurses, patients and carers, we aim to develop an innovative technology that improves clinical outcomes and the patient’s experience.